Eclampsia Clinical Trials

6 recruiting

Frequently Asked Questions

Common questions about Eclampsia clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 113 trials

Recruiting

Placental Imaging Techniques

PregnancyUltrasoundPregnancy Outcomes+5 more
Carilion Clinic60 enrolled1 locationNCT06861309
Recruiting
Not Applicable

Continuous Positive Airway Pressure (CPAP) for Sleep Apnea in Pregnancy

PreeclampsiaObstructive Sleep Apnea of AdultObstetrical Complications
The George Washington University Biostatistics Center1,500 enrolled14 locationsNCT03487185
Recruiting

Placental Biology in Health and Disease

PregnancyPre-EclampsiaFetal Growth Restriction (FGR)+3 more
University of Oxford360 enrolled1 locationNCT07470320
Recruiting
Phase 4

A Randomized, Placebo-controlled Trial of DAPAgliflozin (DAPA) for Cardiovascular Risk Reduction in the Postpartum Period of Hypertensive Pregnancies (HP)

Cardiovascular ComplicationPre-EclampsiaGestational Hypertension+2 more
University of Michigan200 enrolled1 locationNCT06785116
Recruiting
Phase 2

Statin Intervention for Severe Early-Onset Placental Insufficiency. (STATIN-PRE Trial)

Intrauterine Growth Restriction (IUGR)Preeclampsia (PE)Placental Insufficiency
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau154 enrolled2 locationsNCT07098975
Recruiting
Early Phase 1

Vascular Effects of High-Salt After Preeclampsia

PreeclampsiaPreeclampsia Postpartum
Anna Stanhewicz, PhD40 enrolled1 locationNCT06749418
Recruiting

Effects of High Altitude on AMPK Activation

PregnancyPreeclampsiaIUGR
University of Colorado, Denver84 enrolled1 locationNCT02391519
Recruiting
Phase 4

Treatment With Aspirin After Preeclampsia: TAP Trial

Cardiovascular DiseasesHypertensionPregnancy Complications+8 more
Malamo Countouris60 enrolled1 locationNCT06281665
Recruiting

Non-Invasive Preeclampsia Screening and Biobank

Preeclampsia (PE)
Sequenom, Inc.6,550 enrolled21 locationsNCT06643741
Recruiting
Not Applicable

Multiparametric Assessment of Maternal Vascular Function in the Prediction of Hypertensive Disorders of Pregnancy

PreeclampsiaHypertensive Disorder of Pregnancy
IRCCS Azienda Ospedaliero-Universitaria di Bologna400 enrolled1 locationNCT05999851
Recruiting
Phase 3

APPLE: Aspirin to Prevent Pregnancy Loss and Preeclampsia

Pre-EclampsiaPregnancy Loss
University of Pennsylvania1,150 enrolled1 locationNCT06408181
Recruiting

Evaluation of sFlt-1/PlGF Ratio ,OPG and sEng as Predictive Biomarkers in the Diagnosis and Treatment Evaluation of Preeclampsia

PreeclampsiaHypertensive Disorders of PregnancyGestational Hypertension
Ammar Jassim Abed120 enrolled1 locationNCT07349277
Recruiting

Mechanisms of Pregnancy Vascular Adaptations

Pre-EclampsiaVascular Diseases
University of Wisconsin, Madison166 enrolled1 locationNCT03806283
Recruiting
Phase 4

LDA and LMWH vs LDA Alone in High-risk Patients for Preeclampsia Prevention

Pregnancy ComplicationsPreeclampsiaGestational Hypertension+3 more
Alexandra Hospital, Athens, Greece100 enrolled1 locationNCT07361679
Recruiting
Phase 1

A Study to Investigate the Safety, Pharmacodynamic and Pharmacokinetic Characteristics of CBP-4888 in Hospitalized Participants With Preterm Preeclampsia and Their Children up to 24 Months

PreeclampsiasFlt1 Mediated Preterm PreeclampsiaPreterm Preeclampsia
Comanche Biopharma60 enrolled2 locationsNCT07282171
Recruiting

Cardiovascular Risk Assessment in Young Women After Index Pregnancy With and Without Placental Complications

Cardiovascular (CV) RiskPreeclampsia (PE)Fetal Weight
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau1,260 enrolled1 locationNCT07356817
Recruiting

Exosome Cargo From Preeclampsia Patients

Preeclampsia
University of Alabama at Birmingham64 enrolled1 locationNCT04154332
Recruiting

EV Based Platform for Monitoring Therapeutics Response During Pregnancy (ARISE)

Preeclampsia
Ohio State University1,000 enrolled1 locationNCT06249178
Recruiting
Phase 4

Effectiveness of Two Aspirin Doses for Prevention of Hypertensive Disorders of Pregnancy: ASPIRIN TRIAL

PreeclampsiaHypertensive Disorders of PregnancyGestational Hypertension
Ohio State University10,742 enrolled16 locationsNCT06468202
Recruiting
Not Applicable

Fetal Fornix and Hippocampus in Pregnant Women With Early-Onset Preeclampsia

Pre-EclampsiaHippocampus
Ankara Etlik City Hospital84 enrolled1 locationNCT07245056